Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

BACKGROUND/AIMS: Chronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. However, there are no published data on the efficacy of antiviral therapy in Korea. We assessed the safety and efficacy of combination therapy with peginterferon α-2a plus ribavirin for CHC in hemophilia....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Mol Hepatol
Päätekijät: Yang, Suh Yoon, Lee, Hyun Woong, Lee, Youn Jae, Park, Sung Jae, Yoo, Ki Young, Kim, Hyung Joon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Association for the Study of the Liver 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493355/
https://ncbi.nlm.nih.gov/pubmed/26157749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.21.2.125
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia